本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

34.17
-0.6800-1.95%
盘后34.13-0.0379-0.11%19:57 EDT
成交量:178.91万
成交额:6,189.43万
市值:64.88亿
市盈率:-9.67
高:35.60
开:35.43
低:34.15
收:34.85
数据加载中...
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/27

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/26

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/25

SEC问询函

[Cover]Correspondence
2019/06/24

SEC问询函

[Cover]Correspondence
2019/06/24

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/17

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/11

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/05/30

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/29

持股变动声明

Statement of changes in beneficial ownership of securities
2019/05/24

招股说明书

General form for registration of securities under the Securities Act of 1933
2018/12/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/12

持股变动声明

Statement of changes in beneficial ownership of securities
2018/12/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/10

持股变动声明

Statement of changes in beneficial ownership of securities
2018/12/07

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/06

持股变动声明

Statement of changes in beneficial ownership of securities
2018/08/01

超过5%披露

General statement of acquisition of beneficial ownership